Find clinical trials for Acute Myeloid Leukemia (AML) in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Atlanta, GA, USA:
CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1
Atlanta, Georgia, United States and 6 other locations
to be used in future studies in study participants diagnosed with acute myeloid leukemia (AML), myelodysplastic s...
Phase 1, Phase 2
Atlanta, Georgia, United States and 33 other locations
or young adults with a certain kind of blood cancer (FLT3-ITD AML) might be able to join this study if it has come back after remission or i...
Phase 1, Phase 2
Atlanta, Georgia, United States and 26 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Atlanta, Georgia, United States and 81 other locations
A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-500, an oral FLT3 inhibitor, in adult patients with acute leukemia...
Phase 1
Atlanta, Georgia, United States and 22 other locations
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid cells (a white blood cell responsible f...
Phase 3
Atlanta, Georgia, United States and 171 other locations
This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid L...
Phase 1
Atlanta, Georgia, United States and 9 other locations
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Phase 3
Atlanta, Georgia, United States and 103 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Atlanta, Georgia, United States and 36 other locations
This Phase 1 study will assess the safety, tolerability, and preliminary antileukemic activity of ziftomenib in combination with venetoclax and azaci...
Phase 1
Atlanta, Georgia, United States and 44 other locations
Clinical trials
Research sites
Resources
Legal